#1 Clinical Trials Search in Europe

Dydrogesterone

Dydrogesterone is a synthetic progestogen medication that has been studied in various clinical trials for its potential benefits in treating reproductive health conditions. This article summarizes key findings from recent clinical trials investigating the use of dydrogesterone for conditions such as endometriosis, threatened miscarriage, and as luteal phase support in fertility treatments. We’ll explore how this medication may help manage symptoms and improve outcomes for patients dealing with these common gynecological issues.

Table of Contents

What is Dydrogesterone?

Dydrogesterone is a medication that belongs to a class of drugs called progestins. It is a synthetic form of the hormone progesterone, which plays a crucial role in the female reproductive system. Dydrogesterone is also known by its brand name Duphaston[1]. This medication is used to treat various conditions related to hormonal imbalances and reproductive health.

Uses of Dydrogesterone

Dydrogesterone is prescribed for several medical conditions, including:

  • Endometriosis: A condition where tissue similar to the lining of the uterus grows outside the uterus, causing pain and fertility issues[1][4].
  • Threatened miscarriage: When there is a risk of losing the pregnancy in the early stages[8][9].
  • Luteal phase support: To support the uterine lining during fertility treatments[6].
  • Preterm labor: To help prevent premature birth[7].
  • Menstrual disorders: Including irregular periods and painful menstruation[1].
  • Uterine fibroids: Non-cancerous growths in the uterus[10].

How Dydrogesterone Works

Dydrogesterone works by mimicking the effects of natural progesterone in the body. It helps to:

  • Regulate the menstrual cycle
  • Prepare the uterus for pregnancy
  • Support early pregnancy
  • Reduce inflammation and pain associated with endometriosis
  • Prevent ovulation in some cases

Unlike some other forms of progesterone, dydrogesterone does not suppress ovulation when used in lower doses, which can be beneficial for women trying to conceive[1].

Dosage and Administration

The dosage of dydrogesterone varies depending on the condition being treated:

  • For endometriosis: Typically 10 mg taken 2-3 times daily from day 5 to day 25 of the menstrual cycle[1].
  • For threatened miscarriage: Usually 40 mg as a starting dose, followed by 10 mg every 8 hours until symptoms subside[8].
  • For luteal phase support in fertility treatments: 10 mg taken twice daily[6].
  • For preterm labor: 10 mg taken every 8 hours[7].

It’s important to note that dosages should always be determined by a healthcare provider based on individual patient needs and medical history.

Effectiveness

Research has shown that dydrogesterone can be effective in various reproductive health conditions:

  • In endometriosis, it has been shown to reduce pain and improve quality of life[1][4].
  • For threatened miscarriage, studies suggest it may help reduce the risk of pregnancy loss[8].
  • In fertility treatments, it has shown promise as a luteal phase support medication[6].
  • For preterm labor, research is ongoing to determine its effectiveness in prolonging pregnancy[7].

Side Effects

While dydrogesterone is generally well-tolerated, some patients may experience side effects. Common side effects may include:

  • Headache
  • Nausea or vomiting
  • Breast tenderness
  • Dizziness
  • Menstrual irregularities

It’s important to discuss any side effects with your healthcare provider[7][9].

Ongoing Research

Several clinical trials are currently underway to further investigate the uses and effectiveness of dydrogesterone:

  • Its role in improving sexual function in women with endometriosis[4].
  • Comparison with other medications for ovulation suppression in egg donation procedures[5].
  • Its effectiveness in treating endometrial polyps[2].
  • Use in combination with multivitamins for managing uterine fibroids during pregnancy[10].

These ongoing studies aim to provide more comprehensive data on the benefits and potential applications of dydrogesterone in reproductive health.

Condition Dydrogesterone Use Key Findings
Endometriosis 10-20 mg daily, cyclic or continuous regimen Reduced chronic pelvic pain, improved quality of life, potential reduction in ovarian chocolate cyst volume
Threatened Miscarriage 40 mg stat, followed by 10 mg three times daily Under investigation for potential reduction in miscarriage risk before 20 weeks gestation
Luteal Phase Support in FET 10 mg three times daily for two weeks Being compared to placebo for effects on live birth and clinical pregnancy rates
Preterm Labor 10 mg every 8 hours until delivery Under investigation as adjunctive therapy to standard treatment
Sexual Function in Endometriosis 5 mg twice daily for 21 days per cycle Being studied for potential improvements in sexual function using the FSFI

FAQ

  • What is dydrogesterone used for in clinical trials? Dydrogesterone has been studied in clinical trials for various reproductive health conditions, including endometriosis, threatened miscarriage, luteal phase support in fertility treatments, and management of preterm labor.
  • How does dydrogesterone help with endometriosis? Clinical trials have shown that dydrogesterone may help reduce chronic pelvic pain, improve quality of life, and potentially shrink ovarian chocolate cysts in women with endometriosis.
  • Is dydrogesterone effective for threatened miscarriage? Some studies have investigated the use of dydrogesterone in women with threatened miscarriage to potentially reduce the risk of pregnancy loss, though more research is needed to confirm its effectiveness.
  • How is dydrogesterone used in fertility treatments? Dydrogesterone has been studied as a form of luteal phase support in frozen embryo transfer cycles and as part of ovarian stimulation protocols in fertility treatments.
  • Are there any side effects associated with dydrogesterone use? While specific side effects were not detailed in the provided trial information, as with any medication, dydrogesterone may have potential side effects. It's important to discuss these with a healthcare provider before use.

Ongoing Clinical Trials on Dydrogesterone

  • Study of fixed-dose follitropin delta for ovarian stimulation in women undergoing intrauterine insemination treatment for infertility

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Tirzepatide for Women with Overweight or Obesity and Polycystic Ovary Syndrome (PCOS)

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study on Ovarian Stimulation Using Follitropin Delta and Dydrogesterone for Women Donating Eggs

    Recruiting

    1 1 1 1
    Investigated drugs:
    Belgium

  • Study on Random Start Ovarian Stimulation with Follitropin Alfa, Dydrogesterone, and Triptorelin Acetate for Women Undergoing Elective Oocyte Cryopreservation to Prevent Infertility

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

Glossary

  • Endometriosis: A condition where tissue similar to the lining of the uterus grows outside the uterus, often causing pain and fertility issues.
  • Luteal phase support: Hormonal supplementation given after ovulation or embryo transfer to support early pregnancy in fertility treatments.
  • Frozen embryo transfer (FET): A fertility procedure where a previously frozen embryo is thawed and transferred to the uterus.
  • Ovarian chocolate cyst: A type of ovarian cyst filled with old blood, often associated with endometriosis.
  • Threatened miscarriage: Vaginal bleeding during early pregnancy that suggests an increased risk of miscarriage.
  • Preterm labor: The onset of labor before 37 weeks of pregnancy.
  • Female Sexual Function Index (FSFI): A standardized questionnaire used to assess various aspects of female sexual function.
  • Dysmenorrhea: Painful menstrual cramps.
  • CA-125: A protein that can be elevated in some women with endometriosis, used as a biomarker in some studies.

References

  1. https://clinicaltrials.gov/study/NCT03690765
  2. https://clinicaltrials.gov/study/NCT03790215
  3. https://clinicaltrials.gov/study/NCT02921763
  4. https://clinicaltrials.gov/study/NCT04287205
  5. https://clinicaltrials.gov/study/NCT05577806
  6. https://clinicaltrials.gov/study/NCT03859921
  7. https://clinicaltrials.gov/study/NCT03935152
  8. https://clinicaltrials.gov/study/NCT02128685
  9. https://clinicaltrials.gov/study/NCT04788108
  10. https://clinicaltrials.gov/study/NCT02620345